Meloxicam and diclofenac do not change VEGF and PDGF-AB serum levels of platelet-rich plasma


Utku B., DÖNMEZ G., Erisgen G., AKIN Ş., Demirel H. A. , KORKUSUZ F., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.2, pp.570-576, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 47 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.3906/sag-1602-60
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.570-576
  • Keywords: Platelet-rich plasma, PDGF-AB, VEGF, nonsteroidal antiinflammatory drugs, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, HUMAN TENDON CELLS, GROWTH-FACTORS, IN-VITRO, CLINICAL-APPLICATIONS, PROLIFERATION, INHIBITION, PRP

Abstract

Background/aim: Platelet-rich plasma (PRP) application has gained widespread interest for musculoskeletal injuries. Nonsteroidal antiinflammatory drugs are frequently used in sports medicine before and/or after PRP application. Our study seeks to determine whether serum levels of platelet-derived growth factor-AB (PDGF-AB) and vascular endothelial growth factor (VEGF) levels of PRP would be affected by nonsteroidal antiinflammatory drugs.